GEQZX
Price
$61.21
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

GEQZX vs VTSAX

Header iconGEQZX vs VTSAX Comparison
Open Charts GEQZX vs VTSAXBanner chart's image
GuideStone Funds Equity Index Investor
Price$61.21
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
GEQZX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GEQZX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEQZX is a StrongBuy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. GEQZX (4.66B). VTSAX pays higher dividends than GEQZX: VTSAX (1.35) vs GEQZX (0.99). GEQZX was incepted earlier than VTSAX: GEQZX (23 years) vs VTSAX (24 years). GEQZX is a more actively managed with annual turnover of: 5.00 vs. VTSAX (2.00). GEQZX has a lower initial minimum investment than VTSAX: GEQZX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. GEQZX (30.80). VTSAX (87.46) and GEQZX (84.97) have equivalent 5 years return.
GEQZXVTSAXGEQZX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years24 years-
Gain YTD26.38224.891106%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.66B1.73T0%
Annual Yield % from dividends0.991.3573%
Returns for 1 year30.8033.3992%
Returns for 3 years23.7222.82104%
Returns for 5 years84.9787.4697%
Returns for 10 years195.97194.07101%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals